Barceló et al. [32] reported that HNRNPA2B1 acts as a regulator of KRAS-dependent tumourigenesis through the critical pancreatic ductal adenocarcinoma cell signalling pathway PI3K/AKT. The gene discussed is AKT1; the disease is pancreatic ductal adenocarcinoma.